Skip to content

Bausch + Lomb BLCO Proceeds From Derivative Instrument Investing Activities

Proceeds From Derivative Instrument Investing Activities at other companies

Global Business Travel Group logo
Global Business Travel GroupGBTG
$0-100%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$431K
Bausch + Lomb logo
Bausch + LombBLCO
$5M-16.7%
CleanSpark logo
CleanSparkCLSK
$19.89M
ADT logo
ADTADT
-$460K-162%
HQY
HealthEquityHQY
-$2.39M

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.3B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's proceeds from derivative instrument investing activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's proceeds from derivative instrument investing activities?
Bausch + Lomb (BLCO) reported proceeds from derivative instrument investing activities of $5M in Q1 2026.
How has Bausch + Lomb's proceeds from derivative instrument investing activities changed year-over-year?
Bausch + Lomb's proceeds from derivative instrument investing activities decreased by 16.7% year-over-year, from $6M to $5M.
What does proceeds from derivative instrument investing activities mean?
Captures the cash inflows resulting from the settlement or maturity of derivative financial instruments used for investment or hedging purposes. This metric indicates the liquidity generated from the company's financial risk management activities. It helps investors understand the cash flow impact of derivative strategies beyond standard operating activities.